Clinical trialNCT07173803RecruitingPhase 2Interventional

The Progressive Supranuclear Palsy Clinical Trial Platform

SponsorAdam BoxerEnrollment440Progressive Supranuclear Palsy(PSP)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Adam Boxer, MD, PhD
University of California, San Francisco
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Anne-Marie Wills, MD
Massachusetts General Hospital
Principal Investigator
clinicaltrials.gov ↗
Irene Litvan, MD
University of California, San Diego
Principal Investigator
clinicaltrials.gov ↗
Julio Rojas-Martinez, MD, PhD
University of California, San Francisco
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Stanford University
Palo Alto, California, United States
Niyatee Samudra, MD
Not, yet, recruiting
University of California, San Diego
San Diego, California, United States
Katherine Longardner, MD
Not, yet, recruiting
University of California, San Francisco
San Francisco, California, United States
Julio Rojas-Martinez, MD, PhD
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Catherine Isroff, MD
Not, yet, recruiting
Albany Medical College
Albany, New York, United States
Octavian Adam, MD
Not, yet, recruiting
Butler Hospital
Providence, Rhode Island, United States
Edward Huey, MD
Not, yet, recruiting
Houston Methodist
Houston, Texas, United States
Joseph Masdeu, MD, PhD
Not, yet, recruiting
University of Washington
Seattle, Washington, United States
Michael Rosenbloom, MD, FAAN
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AADvac1LM11A-31

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 29 Jul 2026
Primary completion: 28 Sept 2030
Completion: 28 Sept 2030
Last update posted: 21 Aug 2026
Registered enrollment: 440
Registry id: NCT07173803

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.